WINSTON-SALEM, N.C. – Studies in mice suggest that two drugs already approved by the U.S. Food and Drug Administration show promise for treating the complications of lupus, according to Nilamadham Mishra, M.D., in presentations this week at the American College of Rheumatology in Boston. Mishra, a rheumatologist at Wake Forest University Baptist Medical Center, had previously reported that an anti-seizure medication and a chemotherapy drug were effective at preventing skin and kidney disease in mice with lupus. In the current research, he explored why the drugs were effective – with the goal of understanding more about what goes wrong to cause the disease.
